EBOLA SCOURGE MAY BENEFIT MEDIGARD

Written on the 28 November 2014 by Nick Nichols

EBOLA SCOURGE MAY BENEFIT MEDIGARD

THE Ebola scourge could spell good news for Gold Coast company Medigard (ASX: MGZ) as its blood collection device finally hits the market.

The fledgling medical instruments developer says sales of the device are expected to start in March with the product gaining exposure in the global medical industry after featuring in the 2014 Sol Millennium Catalogue.

Medigard last year secured an exclusive licence agreement with Shanghai Sol-Millennium Medical Products Co to manufacture and distribute its Blood Collection Device and Blood Flash Needle.

Medigard chairman Don Channer told the company’s annual general meeting this week that shareholders and directors “look forward to the rewards” ahead thanks to next year’s sales launch of the device.

He says feedback from the Blood Collection Device’s recent showing at the Medica trade fair in Germany had been “positive”.

“Our aspirations of being cheapest and best are being satisfied,” Channer says.

“All manufacturing machinery has been modified for the change in materials and samples of the new device are being circulated in selected locations in the US, UK and hopefully soon Brazil.

“Although it has taken us very much longer than expected to arrive at this position, our experience and success in the evolution of the Blood Collection Device has provided a clear pathway for the commercialisation of future products.”

Medigard says the Blood Collection Device has patents in Australia, the US, Japan, Canada and Europe, while the 3ml vacuum retractable syringe has patents in South Africa, the US, Australia, China, Japan and Canada.

“The Blood Flash Needle which will be the next focus for the company and Sol Millennium has granted patents in Australia, South Africa and Europe,” says Channer.

“With the incidence of such terrible epidemics as Ebola, the need for safety medical devices is increasing.

“We believe the company and Sol Millennium will be well placed to help satisfy this need.”


Author: Nick Nichols

Latest News

ACCC TAKES ACTION AGAINST MURRAY GOULBURN

THE ACCC has begun proceedings against milk processor Murray Goulburn alleging it contravened Australian Consumer Law...

RUMOURS ARDENT LEISURE IS LOOKING TO SELL DREAMWORLD

THE PARENT company of Gold Coast theme park Dreamworld is considering a sale of the struggling business to a Chinese ...

TATTS GROUP REFUSES DUE DILIGENCE TO PACIFIC CONSORTIUM AFTER REVISED $6B OFFER

TAKEOVER target Tatts Group (ASX: TTS) has rejected a revised all-cash $6 billion offer from the private equity group...

AGENTS REPORTING STRONG DEMAND FOR MELBOURNE CBD OFFICE SPACE PURCHASES

SEVEN Melbourne CBD offices have recently sold for more than $11 million in total, demonstrating huge demand for c...

Related News

FURNITURE DISRUPTOR SET TO SHARE HIS ONE OF A KIND BUSINESS MODEL

IT'S no secret that Australians love homemaking. Their ceaseless quest to create the perfect place to call hom...

WEEDING OUT THE ASX'S BURGEONING CANNABIS TREND: 8 COMPANIES TO WATCH

A NICHE is budding on the ASX in the form of medical cannabis, an industry which has been on the country's rad...

FRESH CLASS ACTION TO REVEAL ANOTHER SIDE OF SLATER AND GORDON DOWNFALL

ACA LAWYERS has issued a formal letter of demand to Andrew Grech (pictured), managing director of Slater and Gordo...

STARSHIPS WERE MEANT TO DELIVER DOMINO'S PIZZA

NICKI Minaj may have been off the mark when she declared 'starships were meant to fly'. However, she m...

EVENTS COMING UP

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter